Impaired wound healing of skin is one of the most serious complications of diabetes. However, the pathogenesis of this process is not known, and it is unclear whether impaired insulin signaling could directly affect skin physiology. To elucidate the role of insulin in skin, we studied skin insulin receptor (IR) null mice. The morphology of the skin of newborn IR null mice was normal; however, these mice exhibited decreased proliferation of skin keratinocytes and changes in expression of skin differentiation markers. Due to the short life span of the IR null mice, further characterization was performed in cultured skin keratinocytes that can be induced to differentiate in vitro, closely following the maturation pattern of epidermis in vivo. It was found that despite a compensatory increase in the insulin-like growth factor I receptor autophosphorylation, differentiation of cultured IR null keratinocytes was markedly impaired. In vitro proliferation was not affected as much. Furthermore, although the basal glucose transport system of the null mice was not defective, the insulin-induced increase in glucose transport was abrogated. These results suggest that insulin regulates, via the IR, the differentiation and glucose transport of skin keratinocytes, whereas proliferation is affected by the diabetes milieu of IR knockout mice. (Endocrinology 142: 1234 -1241, 2001) D IABETES mellitus is characterized by impaired insulin signaling, elevated plasma glucose, and a predisposition toward chronic complications involving several tissues. Among the chronic complications of diabetes, the dermatological complications are among the least thoroughly studied. Several diabetes-associated skin lesions and complications have been described (1-5). Some skin lesions, like acanthosis nigricans, are directly associated with states of insulin resistance. However, the most common dermatological complications associated with diabetes are impaired wound healing, foot ulcers, and increased incidence of skin infections.
D IABETES mellitus is characterized by impaired insulin
signaling, elevated plasma glucose, and a predisposition toward chronic complications involving several tissues. Among the chronic complications of diabetes, the dermatological complications are among the least thoroughly studied. Several diabetes-associated skin lesions and complications have been described (1) (2) (3) (4) (5) . Some skin lesions, like acanthosis nigricans, are directly associated with states of insulin resistance. However, the most common dermatological complications associated with diabetes are impaired wound healing, foot ulcers, and increased incidence of skin infections.
Several pathogenic mechanisms have been suggested to be involved in the development of diabetic complications (6 -12) ; these include diabetic microangiopathy, premature aging of the skin fibroblasts, immune-mediated processes, changes in basement membrane structure and function, and others. However, the exact mechanism causing the various pathological conditions in skin is not known.
It is usually assumed that most diabetes complications are induced due to elevated glucose levels associated with this disease. Nevertheless, the diabetic milieu includes, in addition to hyperglycemia, abnormal insulin signaling. One could propose that if indeed insulin has a direct role in the normal function of skin, abnormal insulin signaling might take a part in the development of these complications as well. Little is known, however, about the roles of the insulin receptor (IR) and insulin signaling in normal skin physiology.
To investigate this question we recently studied a model system of skin keratinocytes in culture (13) . In this model system, proliferation and differentiation of the cultured keratinocytes can be controlled by regulating the Ca 2ϩ concentration in the growth medium (14) . Using this model we previously demonstrated that the IR and insulin-like growth factor I (IGF-I) receptor (IGFR) are expressed in skin keratinocytes, and can be stimulated by insulin and IGF-I, resulting in the activation of an intracellular signaling pathway (13) . Furthermore, we have shown that the activity level of both receptors is differentiation dependent (13) .
In the present study we extended these experiments to identify the exact roles of insulin and IGF-I in skin keratinocytes. We studied the skin of IR knockout (IR-KO) transgenic mice in which the IR gene was inactivated by genetic manipulation (15) . We were able to demonstrate, using skin sections as well as isolated keratinocytes, that the lack of IR expression leads to abnormal differentiation of skin keratinocytes, and that insulin-induced glucose transport was abrogated in IR null cells. These results indicate that IR is directly involved in the regulation of skin differentiation and glucose transport, and that abnormal insulin signaling might contribute to abnormalities in these processes.
Materials and Methods Animals
Homozygous IR null nice and wild-type littermates were obtained by crossing heterozygous IR null mice, as described previously (15) . Mice were genotyped using PCR as previously described (15) . Animal experimentation was approved by an appropriate institutional committee.
Cell culture and protein lysate preparation
Primary mouse keratinocytes were prepared and maintained as described previously (13) . Briefly, freshly isolated keratinocytes were cultured in Eagle's medium (Biological Industries, Beit Haemek, Israel) with 10% chelexed FCS (Biological Industries), 1% antibiotics, and a Ca 2ϩ concentration adjusted to 0.05 mm as previously described (13). After 5 days in culture, to induce differentiation the growth medium was switched to medium containing Ca 2ϩ at defined concentrations [0.05 mm (L), 0.12 mm (M), and 1.0 mm (H) Ca 2ϩ ] for 48 h. After 48 h, unless indicated, cells were harvested by scraping into lysis buffer (PBS containing 1% Triton X-100, 1 mm EDTA, 10 mm sodium fluoride, 200 m sodium orthovanadate, and a protease inhibitor cocktail). The lysate was spun down at maximum speed in a microcentrifuge, and the Tritonsoluble supernatant was further analyzed by SDS-PAGE and immunoblotting. The Triton-insoluble pellet was kept for analysis of cytoskeletal proteins, as described below. Protein concentrations were measured using a modified Lowry assay (DC Protein Assay Kit, Bio-Rad Laboratories, Inc., Hercules, CA).
Preparation of cytoskeletal protein samples for analysis of keratin expression
The Triton-insoluble fraction (pellet), obtained as described above, was incubated for 30 min in a special lysis buffer containing ␤-mercaptoethanol (20%) and SDS (5%). The samples were centrifuged for 30 min at maximal speed in a microcentrifuge, and the lysate was further analyzed by SDS-PAGE and Western blot analysis.
Immunoblotting analysis
The protein samples were analyzed by SDS-PAGE and transferred by electroblotting onto nitrocellulose membranes. Immunoblotting was performed as described previously (16) using rabbit polyclonal antibodies against the IR, IGFR, insulin receptor substrate-1 (IRS1), phosphoinositol 3-kinase (p85a), Shc, and Crk (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), keratin 1 and 10 (gifts from Dr. S. H. Yuspa, NCI, NIH), GLUT1 (a gift from Dr. S. Cushman, NIDDK, NIH), or monoclonal antibodies recognizing phosphotyrosine residues (Upstate Biotechnology, Inc.; Lake Placid, NY). Filters were then incubated with the appropriate secondary horseradish peroxidase-conjugated antirabbit (BioRad Laboratories, Inc.) or antimouse (Amersham Pharmacia Biotech, Piscataway, NJ) antibodies. Proteins were detected using an enhanced chemiluminescence protein detection kit (SuperSignal, Pierce Chemical Co., Rockford, IL).
Ligand-stimulated receptor phosphorylation in intact cells and immunoprecipitation
Confluent cultures were incubated in the presence or absence of 10 Ϫ7 m IGF-I (CytoLab, Rehovot, Israel) for 3 min at room temperature. The reaction was terminated by aspiration of the incubation medium followed by quick washes with ice-cold PBS on ice. Cells were lysed in cold lysis buffer (PBS containing 1% Triton X-100, 1 mm EDTA, 10 mm sodium fluoride, 200 m sodium orthovanadate, and a protease inhibitor cocktail). Receptors were immunoprecipitated with antiphosphotyrosine antibodies (Upstate Biotechnology, Inc.), followed by protein A/G-agarose beads (Santa Cruz Biotechnology, Inc.) for 16 -20 h at 4 C. The beads were then washed twice with cold lysis buffer. The immunoprecipitates were run on a SDS-PAGE, and phosphotyrosine-containing proteins were detected by Western blotting using appropriate antibodies, as described above.
2-Deoxy-[ 3 H]glucose (dGlc) uptake
Glucose transport was evaluated by measuring dGlc according to the method described previously (17) . Briefly, on the day of the experiment, cells were washed three times with PBS. Then, 0.1 mm 2-deoxyglucose/ PBS with tracer amounts of dGlc (1 Ci/plate; ARC, St. Louis, MO) was added to the cells. Uptake was allowed to continue for 10 min at room temperature. The reaction was stopped by three quick washes with 1.0 ml cold PBS on ice, and cells were lysed in 1% Triton X-100. The samples were counted in the 3 H window of a Tri-Carb scintillation counter. Uptake was linear under these conditions for up to 15 min (data not shown). Mean values were determined from measurements of triplicate samples under each experimental condition for each experiment.
Thymidine incorporation
Cell proliferation was evaluated by measuring [ 3 H]thymidine incorporation into DNA. Cells were pulsed with [ 3 H]thymidine (1 Ci/ml; ICN, Irvine, CA) for 1 h at 37 C. After incubation, cells were washed three times with PBS, incubated for 15 min at room temperature in 5% trichloroacetic acid, and solubilized in 1% Triton X-100. The radioactivity incorporated into the cells was counted in the 3 H window of a Tri-Carb liquid scintillation counter. Mean values were determined from measurements of triplicate samples under each experimental condition for each experiment.
5Ј-Bromodeoxyuridine (BrdU) labeling and detection
Transgenic mice and control littermates were injected ip with BrdU (Sigma, St. Louis, MO; 250 mg/kg in 0.9% NaCl). Mice were killed 3 h after BrdU injection. Dorsal skin was embedded in OCT (Miles, Elkhart, IN), fresh-frozen, and sectioned. Sections were stained for BrdU by direct immunofluorescence, as described previously (18) , using an FITCconjugated anti-BrdU antibody (Becton Dickinson and Co., San Jose, CA). Briefly, slides were incubated overnight at 4 C with the anti BrdU antibody. After incubation slides were washed twice for 10 min each time with PBS for 10 min and mounted with glycerol buffer containing 1% p-phenylenediamine (Sigma). Fluorescence was examined by laser scanning confocal imaging microscopy (MRC1024, Bio-Rad Laboratories, Inc., Hemel-Hempsted, UK). Epidermal BrdU incorporation was quantitated by counting BrdU-labeled nuclei in basal interfollicular epidermal cells from multiple randomly chosen fields in BrdU-stained sections of skin.
Immunohistochemistry
Immunohistochemical analysis of keratin expression was carried out using monospecific polyclonal antibodies to keratins as previously described (18) . Briefly, dorsal skin from IR-null mice and control littermates was fresh-frozen and sectioned. Sections were incubated overnight with appropriate antibodies against keratins 14, 1, 10, and 6 and against loricrin (all gifts from Dr. S. H. Yuspa, NCI, NIH). Sections were then incubated with biotinylated secondary antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), followed by incubation with horseradish peroxidase-conjugated avidin-biotin complex reagent (Vector Laboratories, Inc., Burlingame, CA) with diaminobenzidine as the substrate (Sigma, St. Louis, MO) and a hematoxylin counterstain.
Results

IR-KO skin structure in vivo is normal
To determine whether insulin has an essential function in skin physiology, we examined several aspects of skin structure and function in IR-KO mice, which genetically lack IR expression. To this end, we first examined the structure of IR-KO skin directly isolated from IR-KO mice. Paraffinembedded skin sections of 2-to 3-day-old IR-KO mice were examined and compared with skin sections of their wild-type (WT) littermates. As shown in Fig. 1 , the skin of the IR-KO mouse appeared normal compared with the WT skin, the epidermis and the dermis were of normal thickness, and the epidermis contained the expected number of cellular layers in each epidermal compartment. In addition, the development of hair follicles and their structure was normal compared with that of WT skin.
Abnormal proliferation of IR-KO skin in vivo
Insulin is known to have several roles in cellular physiology. Specifically, in skin keratinocytes, we have previously shown that insulin and IGF-I are involved in regulation of cellular proliferation and differentiation (13, 19) . Therefore, we studied in more detail the effects of lack of IR expression on these processes. First, we studied the proliferation of skin in vivo. Mice were injected ip with BrdU, and the dividing cells, which incorporate BrdU, were detected by immunodetection of wild-type (IR-WT) and IR knockout (IR-KO) mouse skin sections. As shown in Fig. 2 , the number of proliferating cells in both the dermis and epidermis was significantly lower in IR-KO mice. At higher magnification (Fig. 2 , C and D) it can be seen that in both IR-WT and IR-KO skin the proliferating cells in the epidermis are restricted, as expected, to the basal layer, lying just above the basement membrane. At this higher magnification it is easy to appreciate the decreased number of proliferating cells in the epidermis of IR-KO skin compared with the epidermis of IR-WT skin. In addition, morphometric analysis was performed (18) by counting labeled cells in multiple, randomly selected fields, and expressing their incidence per epidermal length in each section. This analysis gives a quantitative summary of the data, showing that in the IR-KO skin proliferation is reduced by 40% (7.2 vs. 5.2 cells/arbitrary length unit, respectively, in IR-WT and IR-KO skin sections).
IR-KO skin differentiation in vivo is abnormal
We have previously shown that insulin is also involved in the regulation of keratinocyte differentiation (13) . We next examined whether lack of IR expression is associated with abnormalities in this process as well. Differentiation of skin involves upward movement of keratinocytes from the basal membrane toward the surface of the skin. This process is associated with morphological and functional changes in the cells, involving changes in the expression of various proteins. One of the families of proteins expressed in a differentiationdependent manner is the cytoskeletal protein family of keratins. Different sets of keratins are expressed in each step of the differentiation process. Proliferating basal keratinocytes express keratins 5 and 14, whereas cells of the suprabasal layer express keratins 1 and 10 (K1 and K10). In the granular layer cells there is an induction of the expression of another 
FIG. 2. Proliferation of WT and IR-KO skin in vivo.
Skin was removed from 2-day-old WT and homozygous IR-null (IR-KO) mice 3 h after the mice were injected with BrdU. Frozen sections were stained with an anti-BrdU antibody, as described in Materials and Methods. The area marked is shown at higher magnification. Magnification, ϫ100 (upper panels) or ϫ450 (lower panels). Stained nuclei (arrows) are restricted to the basal layer of the epidermis as well as to the hair follicles in the dermis (upper panel).
set of proteins, loricrin and filaggrin, which are components of the cornified envelopes. The expression of other members of the keratin family, such as K6 or K8, is localized to the hair follicles at certain stages of hair developmental. By following the expression of these differentiation markers, we were able to determine that the differentiation process of the skin in vivo is close to normal. As shown (Fig. 3 ) the localization and intensity of the immunohistochemical staining of most differentiation markers representative of the various differentiation stages is similar in null and wild-type skin. In both IR-WT and IR-KO mice the expression of differentiationspecific keratins K1 and K10 is restricted to the suprabasal layer of the epidermis, and loricrin was found to be expressed in the granular compartment. The main change was seen in the localization of K6 expression. In normal skin, K6 expression is restricted to the hair follicles, and it is only transiently expressed in the proliferating epidermis of wounds (20 -22) . As can be seen, in WT skin the expression of K6 was indeed restricted to the hair follicles. In contrast, in IR-KO epidermis K6 was widely expressed in interfollicular epidermis in suprabasal and also some basal cells.
Expression of proteins of the insulin signaling pathway in IR-KO mice
To further investigate the role of IR in skin, we used a model system of cultured primary skin keratinocytes (14) . As mentioned earlier, the cultured murine keratinocytes exhibit many of the characteristics of skin in vivo. Furthermore, we have previously shown that when keratinocytes are induced to differentiate by elevating the concentration of Ca 2ϩ in the growth medium, they express the insulin and IGF-I signaling pathway proteins in a differentiation-dependent manner (13) . The use of this unique model enabled us to perform more complex experiments on keratinocytes isolated from IR-KO mice that could not be carried out in intact skin. We determined the expression and activation of the IGFR as well as other proteins composing the insulin signaling pathway in IR-KO keratinocytes. As can be seen (Fig. 4) , there was no expression, as expected, of the IR in skin keratinocytes isolated from IR-KO mice. The expression levels of IGFR, IRS1, phosphoinositol 3-kinase (p85a), Shc, and Crk were next examined. As shown (Fig. 4) , all of these proteins were expressed similarly in the WT skin keratinocytes and the IR-KO mice regardless of the level of IR expression.
Cellular proliferation in primary cultured skin keratinocytes
Next, we investigated the proliferation and differentiation process of the cells to determine whether the abnormality in proliferation observed in IR-null skin in vivo occurs in vitro as well. Cellular proliferation was evaluated by [ 3 H]thymidine incorporation. During the first days in culture, the IR-KO keratinocytes exhibited a similar proliferation rate as IR-WT cells grown under the same conditions (Fig. 5) . As can be seen, the wild-type nonimmortalized keratinocytes exhausted their replication capacity after a fixed number of cycles in vitro. In comparison, it seemed that there was a larger decrease in the proliferative rate of the IR-KO cells at this stage. However, although this change was repetitive, it was not statistically significant.
Role of IR in skin keratinocyte differentiation
Although we did not find changes in the expression of differentiation markers in IR-KO skin in vivo, we have previously shown an involvement of insulin in the differentia -FIG. 3 . Expression of differentiation markers in IR-null mouse skin. K1, K10, loricrin, and K6 were detected by immunohistochemistry in skin sections from 2-to 3-day-old WT (WT-IR) and IR-null skin (KO-IR), as described in Materials and Methods. tion process of cultured keratinocytes (13) . We suspected that due to the short life span of the IR-KO pups, abnormalities in this process were not yet detected. Thus, we studied the differentiation process in cultured keratinocytes isolated from the IR-KO mice. As mentioned above, cultured primary skin keratinocytes could be induced to differentiate by elevating the concentration of Ca 2ϩ in the growth medium. As in intact skin, specific sets of keratins are expressed in each differentiation stage of the cultured cells (14) . As in intact skin, by following the expression of these proteins, one can estimate the progression of the differentiation process. As can be seen in Fig. 6 , increasing the Ca 2ϩ to above 0.1 mm resulted in the wild-type cells in an increased expression of K1 and K10, the earliest differentiation markers, and later the induction of differentiation was associated with the expression of loricrin and filaggrin. In contrast, keratinocytes from mice lacking IR expression exhibited an abnormal differentiation process. As shown in Fig. 6 , the progress of differentiation, evaluated by following the expected induction of K1 and K10 expression, was delayed in cells isolated from IR-KO mice compared with cells isolated from WT-IR littermates. There was no significant change in other markers examined (Fig. 6) .
Effects of IR knockout on IGFR phosphorylation
To date we have demonstrated that lack of IR in skin results in abnormal proliferation in vivo as well in impaired differentiation of skin in vivo and of cultured keratinocytes. However, despite these abnormalities, IR-KO skin had normal morphology. It is therefore possible that a compensatory mechanism is activated to partially offset the lack of IR. The most obvious possible compensatory candidate is the IGFR, sharing with the IR most of the downstream signaling pathway. Although we have shown that the expression of IGFR did not change, the lack of IR could be associated with a compensatory increase in IGFR activity. To evaluate the effects of lack of IR expression on IGFR activity, cells isolated from IR-WT and IR-KO mice were stimulated with either insulin or IGF-I, and the phosphorylation of IR and IGFR was followed. As shown in Fig. 7A and as was previously shown by us (13) , induction of differentiation is associated with a decrease in IGFR autophosphorylation. In addition, it can be seen that both insulin and IGF-I stimulation result in autophosphorylation of IR and IGFR in WT cells (Fig. 7B) . However, lack of IR expression resulted in an a statistically significant increase in IGF-I-induced IGFR autophosphorylation in proliferating as well as in differentiating IR-KO keratinocytes (Fig. 7, A-C) , demonstrating that activation of the IGFR is elevated in compensation for the lack of IR signaling. In contrast, there was no compensatory increase in IGFR autophosphorylation when cells were stimulated by insulin (Fig. 7B) . Interestingly, the phosphorylation of IRS1 was inhibited by 30%, on the average (Fig. 7B) . Thus, the increase in IGFR autophosphorylation cannot compensate for the lack of IR-induced IRS1 phosphorylation.
FIG. 4. Expression levels of proteins of the insulin and IGF-I signaling pathways in WT and IR-KO keratinocytes. Proliferating keratinocytes of WT and IR-null (IR-KO) mice were maintained for 5 days in low Ca
2ϩ medium (0.05 mM) until they reached 80% confluence. Differentiation was then induced by elevating the Ca 2ϩ concentration in the growth medium to 0.12 mM (M) and 1.0 mM (H) for 48 h. The total protein lysate was extracted from cells, and 20 g extract were analyzed by Western blotting using specific antibodies against the proteins. A representative experiment of three separate replications is shown. 
Glucose transport system in IR-KO keratinocytes
It is known that skin is not a classical insulin target tissue. However, we have previously shown that chronic insulin and IGF-I stimulation lead to increased glucose transport (23) . Therefore, we followed the effects of the absence of IR on the regulation of glucose transport. The main glucose transporter protein expressed in skin keratinocytes is GLUT1. Lack of IR expression had no effect on GLUT1 expression (Fig. 8A) . We next examined the glucose transport rate using dGlc (Fig. 8B) . Proliferating skin keratinocytes isolated from WT-IR and IR-KO mice had similar basal dGlc uptake of 66.7 and 63.3 dpm/g protein⅐min, respectively. Acute insulin stimulation did not affect the dGlc uptake rate of either cell type (data not shown). On the other hand, chronic insulin exposure increased the glucose transport rate of the WT cells, whereas it was unchanged in IR-KO cells. Under similar conditions elevation of the glucose transport rate into the cells in response to chronic IGF-I stimulation was similar in WT and IR-KO mice (Fig. 8B) . These results suggest that the effects of insulin on glucose transport, attributed by most researchers to the cross-activation of the IGFR by insulin, are actually transmitted via insulin-induced activation of the IR per se.
Discussion
In the present study we have shown that insulin has a unique role in skin physiology, a role that is mediated via its own receptor and is distinct from the roles of IGF-I in skin. Lack of IR expression results in reduced proliferation of skin in vivo. Furthermore, we demonstrated that in IR-KO pups, the lack of IR expression also results in an abnormal differentiation process in the intact skin tissue. Moreover, it was shown that the Ca 2ϩ -induced differentiation in cultured skin keratinocytes was inhibited.
We have previously shown that in skin keratinocytes, insulin and IGF-I have different roles in skin proliferation and differentiation that are mediated via distinct signaling pathways (13, 19) . Involvement of insulin in cellular proliferation and differentiation was shown in other tissues as well, including 3T3-L1 preadipocytes and C2 muscle cells (24, 25) . A striking similarity can be found when comparing our results to those found in gastrointestinal enterocytes (26) . IGFR and secreted IGF-I appear to be characteristic of proliferating cryptic cells, whereas differentiating cells show higher insulin binding and no secretion of IGF-I. However, this is the first time that a direct link has been demonstrated between IR expression/signaling and the cellular processes of proliferation and differentiation. Interestingly, the lack of IR was not associated with impairment of the adipocyte differentiation process, demonstrating a tissue-specific involvement of insulin and IGF-I in these processes (27) .
Our studies indicate differences between the proliferation process in vivo and that of cultured skin keratinocytes in vitro. There was a marked decrease in the proliferation of basal keratinocytes in IR-KO skin compared with IR-WT skin. In contrast, there was not a statistically significant difference in the thymidine proliferation rate between cultured IR-KO and IR-WT cells. We postulate that this difference results from the effects of the diabetes milieu developing in the IR-KO mouse on the proliferation process, especially to the hyperglycemia developing in the IR-KO pups a few hours after birth. Indeed, in recent studies we found (unpublished results) that incubating skin keratinocytes in high glucose for several days results in a decrease in cell proliferation compared with that of cells incubated in physiological levels of glucose.
Differences in the differentiation of IR-KO keratinocytes in vivo vs. that of cells cultured and induced to differentiate in vitro were also found. The differentiation process of intact skin seemed to be slightly impaired, whereas it is significantly altered in cultured keratinocytes of the same animal. The main change observed in the IR-KO skin was an increase in K6 expression in the IR-KO epidermis compared with the IR-WT skin. In normal murine and human epidermis, K6 is expressed constitutively in a variety of internal stratified epithelia as well as in palmoplantar epidermis and specialized cells of the hair follicle (20) . K6 expression was also shown to be induced during wound healing, skin disorders such as psoriasis, skin tumors, and in response to the topical applications of retinoic acid and phorbol esters (21, 22, 28) . It was initially thought that K6 expression was associated with hyperproliferative conditions; however, it has been more recently demonstrated that K6 is induced whenever the normal biology of keratinocytes is disturbed (29 -31) . In the IR-KO epidermis, the increase in K6 expression was associated with suppressed keratinocyte proliferation. Such a case was shown in transforming growth factor-␤-overexpressing transgenic mice (32) , in which K6 was highly expressed, and keratinocyte proliferation was suppressed. It was recently shown that K6 null mice exhibited severe blistering and neonatal lethality (33) , demonstrating that K6 has an important role in skin and possibly in other organs as well. However, the functional significance of increased expression of K6 on keratinocyte biology under various conditions is as yet unknown. In cultured keratinocytes, on the other hand, K6 expression is constitutively elevated, probably due to the destruction of the normal skin structure and cell to cell contacts (14) . There was no other change in the expression or localization of the other differentiation markers tested in the skin samples derived from IR-KO mice, in contrast to the abnormally reduced expression of K1 and K10 in the differentiated cultured keratinocytes. The discrepancy probably results from the short life span of the IR-KO mice. These mice die of ketoacidosis within 3-5 days of birth (15) . Indeed, it is possible that other abnormalities would have developed later in life if this phenotype was not lethal. Support for this possibility can be found in studies showing (34) that even though the skin of IR-KO mice is normal in appearance, the epidermis of the IGFR/IR double nullizygous mouse is thinner than that of the IGFR single mutant. Another explanation for the fewer changes seen in intact skin could be that in the intact animal a compensatory mechanism is activated, which does not exist in the cultured keratinocytes. For example, such a mechanism could involve a process dependent, partially or fully, on the dermal fibroblasts. It is known that local IGF-I and IGF-binding proteins play a role in regulation of IGFR activity (35) (36) (37) . In addition, IGF-2 was shown to participate in growth-promoting interactions with the IR during development (34) . Such IGF regulatory factors could be secreted not only by the keratinocytes, but also by the dermal fibroblasts; their absence in cell culture could lead to further or facilitated deterioration of cellular physiology.
In the study we have also demonstrated that IGFR activity is increased in compensation for the lack of IR. It is generally accepted that the main role of insulin is regulation of glucose transport and metabolism, whereas IGF-I is involved in cellular growth and differentiation. However, it has been shown that IGF-I can affect glucose transport, and conversely, insulin may affect proliferation and differentiation (38, 39) . Furthermore, functionally important IR-IGFR hybrids have been demonstrated on the cell surface (40 -42) . Finally, it is known that insulin and IGF-I can cross-activate IGFR and IR, respectively (38, 39) . All of the above phenomena were shown to occur in cultured murine keratinocytes (13, 23) and could be used by the cells to induce compensatory activity of IGF-I or the IGFR in the absence of IR. Physiological support for the compensatory role of IGFR in the absence of IR can be found in a recent study showing that IGF-I caused a rapid and sustained decrease in plasma glucose in IR-KO mice. It was suggested that this effect was due to IGF-I stimulation of glucose uptake in skeletal muscle, although this hypothesis was not proven (43) . Nonetheless, we have recently shown that in cultured IR-KO muscle cells, there is a compensatory increase in both the expression as well as the activity of the IGFR (44) . Theoretically, this compensatory increase could allow the cells and tissues to develop to a certain point, as was suggested in leprechaun patients (45, 46) . However, it is clear that IGFR overactivation was not able to replace all of the activities of insulin, as can be deduced from the severe phenotype of the leprechaun patients and the IR-KO mice. In addition, we found that IRS1 phosphorylation was not increased, but, rather, was inhibited in the IR null skin keratinocytes. Furthermore, although we have demonstrated that insulin can autophosphorylate the IGFR, insulin-induced glucose transport still requires the IR and is abolished in IR-KO cells. One could further suggest that as insulin and IGF-I play different roles in keratinocyte proliferation and differentiation, overactivation of the IGFR could by itself lead to some of the abnormalities seen in the IR-KO mice.
In conclusion, we demonstrated that insulin plays an active role in skin physiology. Indeed, it is plausible that states of insulin resistance such as diabetes might result in abnormal skin function, leading to impaired wound healing. It is hoped that further identification of the roles of insulin and IGF-I in skin will lead us to a better understanding of the pathogenesis of diabetic skin complications and possibly to the development of treatments and prophylaxis against these complications.
